Bacterial resistance to CRISPR-Cas antimicrobials
Abstract In the age of antibiotic resistance and precise microbiome engineering, CRISPR-Cas antimicrobials promise to have a substantial impact on the way we treat diseases in the future. However, the efficacy of these antimicrobials and their mechanisms of resistance remain to be elucidated. We sys...
Guardado en:
Autores principales: | Ruben V. Uribe, Christin Rathmer, Leonie Johanna Jahn, Mostafa Mostafa Hashim Ellabaan, Simone S. Li, Morten Otto Alexander Sommer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/abe1e98c25074767ad4e8e079518f630 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dominant resistance and negative epistasis can limit the co-selection of de novo resistance mutations and antibiotic resistance genes
por: Andreas Porse, et al.
Publicado: (2020) -
Forecasting the dissemination of antibiotic resistance genes across bacterial genomes
por: Mostafa M. H. Ellabaan, et al.
Publicado: (2021) -
Dissemination of antibiotic resistance genes from antibiotic producers to pathogens
por: Xinglin Jiang, et al.
Publicado: (2017) -
Major bacterial lineages are essentially devoid of CRISPR-Cas viral defence systems
por: David Burstein, et al.
Publicado: (2016) -
Chromosomal barcoding as a tool for multiplexed phenotypic characterization of laboratory evolved lineages
por: Leonie Johanna Jahn, et al.
Publicado: (2018)